Gero
Using next-gen AI to design drugs against complex disorders
Gero has raised €1.9M across 1 funding round from 1 investor, most recently a Series A round in Aug 2020. Based in Russia; founded 2012; active in AI. Data as of 28 Oct 2026.
Total raised
€1.9M
€1,876,173
Funding rounds
1
Investors
1
distinct backers
Active since
2020-08
latest 2020-08
Funding by year
EUR raised per yearGero — funding by year — interactive chart.
Data table
| Gero — funding by year | |
|---|---|
| 2020 | €1.9M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-08-04 | Series A | €1.9M | Bulba Ventures | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Helsing€2.9BGermany · AI
- UiPath€1.7BRomania · AI
- ElevenLabs€1.2BUK · AI
- Ineffable Intelligence€936MUK · AI
- Advanced Machine Intelligence (AMI)€885MFrance · AI
Global coverage: FundingData